{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:22:15Z","timestamp":1794262935271,"version":"4.9.0"},"reference-count":78,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:p>MicroRNAs (miRNAs), a class of small noncoding RNA molecules, play a pivotal regulatory role in bladder cancer initiation, progression, and metastasis through precise modulation of gene expression. This review systematically elucidates miRNA biogenesis pathways (canonical and non-canonical), dynamic regulatory mechanisms, and their multidimensional functional networks in bladder cancer. In bladder carcinogenesis, specific miRNAs significantly inhibit tumor cell proliferation and metastasis by targeting key genes such as p21, TAGLN2, and PROM2. Furthermore, miRNAs mediate immune evasion mechanisms by remodeling the tumor immune microenvironment through regulation of T-cell differentiation and myeloid-derived suppressor cell functions. Emerging miRNA-based therapeutic strategies, including replacement therapy and antisense oligonucleotide technology, demonstrate clinical potential in enhancing chemosensitivity and suppressing tumor progression. However, critical challenges persist in understanding the molecular interaction networks underlying miRNA dynamics, spatiotemporal heterogeneity of non-canonical pathways, and clinical translation mechanisms. Future investigations should integrate multi-omics data with systems biology approaches to decipher core molecular targets within miRNA regulatory networks, thereby advancing the optimization of precision diagnosis and treatment systems for bladder cancer.<\/jats:p>","DOI":"10.1097\/js9.0000000000003947","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:00:17Z","timestamp":1763056817000},"page":"4840-4849","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["MicroRNAs in bladder cancer: biogenesis, function, and therapeutic strategies"],"prefix":"10.1097","volume":"112","author":[{"given":"Lei","family":"Gao","sequence":"first","affiliation":[{"name":"The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People\u2019s Hospital, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[{"name":"The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People\u2019s Hospital, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Shang","sequence":"additional","affiliation":[{"name":"The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People\u2019s Hospital, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hangzhou First People\u2019s Hospital, School of Medicine, Westlake University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjiu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Affiliated Hangzhou First People\u2019s Hospital, School of Medicine, Westlake University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9570-1373","authenticated-orcid":false,"given":"Huadong","family":"He","sequence":"additional","affiliation":[{"name":"The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People\u2019s Hospital, Hangzhou, China"},{"name":"Department of Urology, Affiliated Hangzhou First People\u2019s Hospital, School of Medicine, Westlake University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"R1-20260512","doi-asserted-by":"crossref","first-page":"215\u201333","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"R2-20260512","doi-asserted-by":"crossref","first-page":"30\u201343","DOI":"10.1016\/j.molcel.2021.11.026","article-title":"Life of RISC: formation, action, and degradation of RNA-induced silencing complex","volume":"82","author":"Iwakawa","year":"2022","journal-title":"Mol Cell"},{"key":"R3-20260512","doi-asserted-by":"crossref","first-page":"120\u201331","DOI":"10.1016\/j.semcancer.2021.05.004","article-title":"miRNA dysregulation is an emerging modulator of genomic instability","volume":"76","author":"Ferragut Cardoso","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"R4-20260512","first-page":"45\u201359","article-title":"Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt\/\u03b2-catenin pathway and upregulating PTEN","volume":"44","author":"Shan","year":"2021","journal-title":"Cell Oncol Dordr"},{"key":"R5-20260512","first-page":"100082","article-title":"Transparency In The reporting of Artificial INtelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Premier J Sci"},{"key":"R6-20260512","doi-asserted-by":"crossref","first-page":"108386","DOI":"10.1016\/j.pharmthera.2023.108386","article-title":"Arsenic resistance protein 2 and microRNA biogenesis: biological implications in cancer development","volume":"244","author":"Yuan","year":"2023","journal-title":"Pharmacol Ther"},{"key":"R7-20260512","doi-asserted-by":"crossref","first-page":"21\u201337","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of microRNA function in animals","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R8-20260512","doi-asserted-by":"crossref","first-page":"1374\u201387","DOI":"10.1016\/j.cell.2015.05.010","article-title":"Functional anatomy of the human microprocessor","volume":"161","author":"Nguyen","year":"2015","journal-title":"Cell"},{"key":"R9-20260512","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.molcel.2020.02.016","article-title":"Cryo-EM structures of human drosha and DGCR8 in complex with primary microrna","volume":"78","author":"Partin","year":"2020","journal-title":"Mol Cell"},{"key":"R10-20260512","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.molcel.2020.02.024","article-title":"Structural basis for pri-miRNA recognition by drosha","volume":"78","author":"Jin","year":"2020","journal-title":"Mol Cell"},{"key":"R11-20260512","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s42003-020-1071-5","article-title":"Select amino acids in DGCR8 are essential for the UGU-pri-miRNA interaction and processing","volume":"3","author":"Dang","year":"2020","journal-title":"Commun Biol"},{"key":"R12-20260512","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1038\/s41467-020-15674-2","article-title":"Mismatched and wobble base pairs govern primary microRNA processing by human microprocessor","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"R13-20260512","doi-asserted-by":"crossref","first-page":"31\u201348","DOI":"10.1002\/wrna.1195","article-title":"Ribonuclease III mechanisms of double-stranded RNA cleavage","volume":"5","author":"Nicholson","year":"2014","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"R14-20260512","doi-asserted-by":"crossref","first-page":"95\u201398","DOI":"10.1126\/science.1090599","article-title":"Nuclear export of microRNA precursors","volume":"303","author":"Lund","year":"2004","journal-title":"Science"},{"key":"R15-20260512","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41467-020-15598-x","article-title":"XPO5 promotes primary miRNA processing independently of RanGTP","volume":"11","author":"Wang","year":"2020","journal-title":"Nat Commun"},{"key":"R16-20260512","doi-asserted-by":"crossref","first-page":"1152\u201357","DOI":"10.1126\/science.abl4546","article-title":"Mechanism of siRNA production by a plant Dicer-RNA complex in dicing-competent conformation","volume":"374","author":"Wang","year":"2021","journal-title":"Science"},{"key":"R17-20260512","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.cell.2018.03.080","article-title":"Cryo-EM structure of human dicer and its complexes with a pre-miRNA substrate","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"R18-20260512","doi-asserted-by":"crossref","first-page":"6568\u201376","DOI":"10.1093\/nar\/gkt361","article-title":"Differential roles of human dicer-binding proteins TRBP and PACT in small RNA processin","volume":"41","author":"Lee","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"R19-20260512","doi-asserted-by":"crossref","first-page":"331\u201338","DOI":"10.1038\/s41586-023-05723-3","article-title":"Structure of the human DICER-pre-miRNA complex in a dicing state","volume":"615","author":"lee","year":"2023","journal-title":"Nature"},{"key":"R20-20260512","doi-asserted-by":"crossref","first-page":"111528","DOI":"10.1016\/j.biopha.2021.111528","article-title":"MicroRNA: a signature for cancer progression","volume":"138","author":"Hussen","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"R21-20260512","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.molcel.2022.09.002","article-title":"Structural basis of microRNA biogenesis by Dicer-1 and its partner protein Loqs-PB","volume":"82","author":"Jouravleva","year":"2022","journal-title":"Mol Cell"},{"key":"R22-20260512","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.cell.2018.02.051","article-title":"Phase transitions in the assembly and function of human miRISC","volume":"173","author":"Sheu-Gruttadauria","year":"2018","journal-title":"Cell"},{"key":"R23-20260512","doi-asserted-by":"crossref","first-page":"1037\u201340","DOI":"10.1126\/science.1221551","article-title":"The crystal structure of human Argonaute2","volume":"336","author":"Schirle","year":"2012","journal-title":"Science"},{"key":"R24-20260512","doi-asserted-by":"crossref","first-page":"eadf0597","DOI":"10.1126\/sciadv.adf0597","article-title":"The integrator complex regulates microRNA abundance through RISC loading","volume":"9","author":"Kirstein","year":"2023","journal-title":"Sci Adv"},{"key":"R25-20260512","article-title":"The biogenesis and regulation of animal microRNAs","author":"Kim","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R26-20260512","doi-asserted-by":"crossref","first-page":"e1680","DOI":"10.1002\/wrna.1680","article-title":"Biogenesis, characterization, and functions of mirtrons","volume":"13","author":"Salim","year":"2022","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"R27-20260512","doi-asserted-by":"crossref","first-page":"1568\u201380","DOI":"10.1016\/j.cell.2013.11.027","article-title":"Mammalian 5\u2032-capped microRNA precursors that generate a single microRNA","volume":"155","author":"Xie","year":"2013","journal-title":"Cell"},{"key":"R28-20260512","doi-asserted-by":"crossref","first-page":"1694\u201398","DOI":"10.1126\/science.1190809","article-title":"A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity","volume":"328","author":"Cifuentes","year":"2010","journal-title":"Science"},{"key":"R29-20260512","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-019-0805-7","article-title":"The interplay between m6A RNA methylation and noncoding RNA in cancer","volume":"12","author":"Ma","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R30-20260512","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-023-01466-w","article-title":"Small RNA modifications: regulatory molecules and potential applications","volume":"16","author":"Xiong","year":"2023","journal-title":"J Hematol Oncol"},{"key":"R31-20260512","doi-asserted-by":"crossref","first-page":"26\u201339","DOI":"10.1016\/j.tibs.2022.06.005","article-title":"MicroRNA turnover: a tale of tailing, trimming, and targets","volume":"48","author":"Han","year":"2023","journal-title":"Trends Biochem Sci"},{"key":"R32-20260512","doi-asserted-by":"crossref","first-page":"eabc9359","DOI":"10.1126\/science.abc9359","article-title":"The ZSWIM8 ubiquitin ligase mediates target-directed microRNA degra-dation","volume":"370","author":"Shi","year":"2020","journal-title":"Science"},{"key":"R33-20260512","doi-asserted-by":"crossref","first-page":"2628\u201347","DOI":"10.7150\/ijbs.47203","article-title":"miRNA-based biomarkers, therapies, and resistance in cancer","volume":"16","author":"He","year":"2020","journal-title":"Int J Biol Sci"},{"key":"R34-20260512","doi-asserted-by":"crossref","first-page":"251\u201385","DOI":"10.1146\/annurev.pathol.4.110807.092230","article-title":"Molecular pathogenesis and diagnostics of bladder cancer","volume":"4","author":"Mitra","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"R35-20260512","doi-asserted-by":"crossref","first-page":"106475","DOI":"10.1016\/j.phrs.2022.106475","article-title":"Crosstalk of miRNAs with signaling networks in bladder cancer progression: therapeutic, diagnostic and prognostic functions","volume":"185","author":"Hashemi","year":"2022","journal-title":"Pharmacol Res"},{"key":"R36-20260512","doi-asserted-by":"crossref","first-page":"6009\u201319","DOI":"10.1002\/cam4.3263","article-title":"Exosome-transmitted microRNA-133b inhibited bladder cancer proliferation by upregulating dual-specificity protein phosphatase 1","volume":"9","author":"Cai","year":"2020","journal-title":"Cancer Med"},{"key":"R37-20260512","first-page":"4910\u201323","article-title":"MicroRNA-133b suppresses bladder cancer malignancy by targeting TAGLN2-mediated cell cycle","volume":"234","author":"Zhao","year":"2019","journal-title":"J Cell Physiol"},{"key":"R38-20260512","doi-asserted-by":"crossref","first-page":"676588","DOI":"10.3389\/fcell.2021.676588","article-title":"Long non-coding RNA RMRP in the pathogenesis of human disorders","volume":"9","author":"Hussen","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R39-20260512","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41419-021-04296-1","article-title":"LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer","volume":"12","author":"Luo","year":"2021","journal-title":"Cell Death Dis"},{"key":"R40-20260512","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13046-023-02932-6","article-title":"EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance","volume":"43","author":"Wei","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"R41-20260512","doi-asserted-by":"crossref","first-page":"216613","DOI":"10.1016\/j.canlet.2024.216613","article-title":"N6-methyladenosine-modified circPSMA7 enhances bladder cancer malignancy through the miR-128-3p\/MAPK1 axis","volume":"585","author":"Yi","year":"2024","journal-title":"Cancer Lett"},{"key":"R42-20260512","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41419-020-02935-7","article-title":"UBAC2 promotes bladder cancer proliferation through BCRC-3\/miRNA-182-5p\/p27 axis","volume":"11","author":"Gu","year":"2020","journal-title":"Cell Death Dis"},{"key":"R43-20260512","doi-asserted-by":"crossref","first-page":"1696\u2013709","DOI":"10.1038\/s41388-019-1092-z","article-title":"Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p\/MMP9 axis","volume":"39","author":"Liu","year":"2020","journal-title":"Oncogene"},{"key":"R44-20260512","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1186\/s12885-020-07523-8","article-title":"microRNA-451a promoter methylation regulated by DNMT3B expedites bladder cancer development via the EPHA2\/PI3K\/AKT axis","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Cancer"},{"key":"R45-20260512","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41419-022-04936-0","article-title":"Tumor suppressive role of microRNA-139-5p in bone marrow mesenchymal stem cells-derived extracellular vesicles in bladder cancer through regulation of the KIF3A\/p21 axis","volume":"13","author":"Xiang","year":"2022","journal-title":"Cell Death Dis"},{"key":"R46-20260512","doi-asserted-by":"crossref","first-page":"643362","DOI":"10.3389\/fonc.2021.643362","article-title":"Circular RNA TAF4B promotes bladder cancer progression by sponging miR-1298-5p and regulating TGFA expression","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"R47-20260512","first-page":"4266\u201382","article-title":"Sodium butyrate inhibits migration and induces AMPK-mTOR pathway-dependent autophagy and ROS-mediated apoptosis via the miR-139-5p\/Bmi-1 axis in human bladder cancer cells","volume":"34","author":"Wang","year":"2020","journal-title":"FASEB J"},{"key":"R48-20260512","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.3390\/ijms23105319","article-title":"Wnt\/\u03b2-catenin signalling and its cofactor BCL9L have an oncogenic effect in bladder cancer cells","volume":"23","author":"Kotolloshi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R49-20260512","doi-asserted-by":"crossref","first-page":"120941","DOI":"10.1016\/j.lfs.2022.120941","article-title":"MicroRNA-621 functions as a metastasis suppressor in colorectal cancer by directly targeting LEF1 and suppressing Wnt\/\u03b2-catenin signaling","volume":"308","author":"Chen","year":"2022","journal-title":"Life Sci"},{"key":"R50-20260512","doi-asserted-by":"crossref","first-page":"12177\u201396","DOI":"10.1096\/fj.202000347R","article-title":"The role of exosomal miR-375-3p: a potential suppressor in bladder cancer via the Wnt\/\u03b2-catenin pathway","volume":"34","author":"Li","year":"2020","journal-title":"Faseb J"},{"key":"R51-20260512","first-page":"5680353","article-title":"Exosome-mediated miR-4792 transfer promotes bladder cancer cell proliferation via enhanced FOXC1\/c-Myc signaling and Warburg effect","volume":"2022","author":"Wu","year":"2022","journal-title":"J Oncol"},{"key":"R52-20260512","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13046-021-01846-5","article-title":"A positive feedback loop between TAZ and miR-942-3p modulates proliferation, angio-genesis, epithelial-mesenchymal transition process, glycometabolism and ROS homeostasis in human bladder cancer","volume":"40","author":"Wang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"R53-20260512","doi-asserted-by":"crossref","first-page":"121\u201334","DOI":"10.3109\/10409238.2015.1117054","article-title":"Dysregulation of microRNA biogenesis machinery in cancer","volume":"51","author":"Hata","year":"2016","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"R54-20260512","doi-asserted-by":"crossref","first-page":"1216\u201323","DOI":"10.1172\/JCI81136","article-title":"Exosomes and tumor-mediated immune suppression","volume":"126","author":"Whiteside","year":"2016","journal-title":"J Clin Invest"},{"key":"R55-20260512","doi-asserted-by":"crossref","first-page":"djx034","DOI":"10.1093\/jnci\/djx034","article-title":"Immune modulatory microRNAs involved in tumor attack and tumor immune escape","volume":"109","author":"Eichm\u00fcller","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"R56-20260512","doi-asserted-by":"crossref","first-page":"1628\u201338","DOI":"10.1002\/ijc.33731","article-title":"Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization","volume":"149","author":"Groth","year":"2021","journal-title":"Int, J, Cancer"},{"key":"R57-20260512","doi-asserted-by":"crossref","first-page":"105228","DOI":"10.1016\/j.phrs.2020.105228","article-title":"FATP2-targeted therapies - A role beyond fatty liver disease","volume":"161","author":"Qiu","year":"2020","journal-title":"Pharmacol Res"},{"key":"R58-20260512","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-024-01968-2","article-title":"Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by up-regulating fatty acid transporter protein 2 and down-regulating receptor-interacting protein kinase 3 in PMN-MDSCs","volume":"23","author":"Shi","year":"2024","journal-title":"Mol Cancer"},{"key":"R59-20260512","doi-asserted-by":"crossref","first-page":"e1635","DOI":"10.1002\/wrna.1635","article-title":"MicroRNA-99 family in cancer and immunity","volume":"12","author":"Eniafe","year":"2021","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"R60-20260512","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/cells9010029","article-title":"MicroRNA-based combinatorial cancer therapy: effects of microRNAs on the efficacy of anti-cancer therapies","volume":"9","author":"Seo","year":"2019","journal-title":"Cells"},{"key":"R61-20260512","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.3390\/ijms23052805","article-title":"miRNAs in cancer (review of literature)","volume":"23","author":"Smolarz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R62-20260512","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-4598-13-8","article-title":"Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy","volume":"13","author":"Li","year":"2014","journal-title":"Mol Cancer"},{"key":"R63-20260512","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41419-022-04791-z","article-title":"Hsa-miR-30a-3p overcomes the acquired protective autophagy of bladder cancer in chemotherapy and suppresses tumor growth and muscle invasion","volume":"13","author":"Hwang","year":"2022","journal-title":"Cell Death Dis"},{"key":"R64-20260512","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.3390\/ijms22094751","article-title":"Pharmacological inhibition of miR-130 family suppresses bladder tumor growth by targeting various oncogenic pathways via PTPN1","volume":"22","author":"Monoe","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R65-20260512","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-025-03391-x","article-title":"MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications","volume":"44","author":"Martino","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"R66-20260512","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/polym16182606","article-title":"Recent applications of PLGA in drug delivery systems","volume":"16","author":"Yang","year":"2024","journal-title":"Polymers (Basel)"},{"key":"R67-20260512","doi-asserted-by":"crossref","first-page":"533\u201343","DOI":"10.1016\/j.jconrel.2022.05.027","article-title":"Exosomes: large-scale production, isolation, drug loading efficiency, and biodistribution and uptake","volume":"347","author":"Kimiz-gebologlu","year":"2022","journal-title":"J Control Release"},{"key":"R68-20260512","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13046-021-01865-2","article-title":"Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion","volume":"40","author":"Wu","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"R69-20260512","doi-asserted-by":"crossref","first-page":"1630\u201337","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br J Cancer"},{"key":"R70-20260512","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13045-023-01468-8","article-title":"Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study","volume":"16","author":"Tassone","year":"2023","journal-title":"J Hematol Oncol"},{"key":"R71-20260512","doi-asserted-by":"crossref","first-page":"1067\u201370","DOI":"10.1038\/nature08956","article-title":"Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles","volume":"464","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"R72-20260512","doi-asserted-by":"crossref","first-page":"1386\u201396","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"Van Zandwijk","year":"2017","journal-title":"Lancet Oncol"},{"key":"R73-20260512","doi-asserted-by":"crossref","first-page":"995\u20131004","DOI":"10.2215\/CJN.0000000000000458","article-title":"A randomized controlled clinical trial testing effects of lademirsen on kidney function decline in adults with Alport syndrome","volume":"19","author":"Gale","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"R74-20260512","doi-asserted-by":"crossref","first-page":"114113","DOI":"10.1016\/j.addr.2022.114113","article-title":"RNAi-based therapeutics and tumor targeted delivery in cancer","volume":"182","author":"Kara","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"R75-20260512","doi-asserted-by":"crossref","first-page":"987\u201392","DOI":"10.1080\/17460441.2020.1765770","article-title":"Challenges identifying efficacious miRNA therapeutics for cancer","volume":"15","author":"Segal","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"R76-20260512","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13059-025-03566-x","article-title":"Extracellular vesicle-derived miRNA-mediated cell-cell communication inference for single-cell transcriptomic data with miRTalk","volume":"26","author":"Shao","year":"2025","journal-title":"Genome Biol"},{"key":"R77-20260512","doi-asserted-by":"crossref","first-page":"110015","DOI":"10.1016\/j.celrep.2021.110015","article-title":"MapToCleave: high-throughput profiling of microRNA biogenesis in living cells","volume":"37","author":"Kang","year":"2021","journal-title":"Cell Rep"},{"key":"R78-20260512","doi-asserted-by":"crossref","first-page":"809\u201324","DOI":"10.1016\/j.trecan.2024.06.006","article-title":"Small molecules targeting microRNAs: new opportunities and challenges in precision cancer therapy","volume":"10","author":"Jurj","year":"2024","journal-title":"Trends Cancer"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003947","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:24:15Z","timestamp":1778581455000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003947","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"2025-04-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}